Saroja Pharma Industries Financial Analysis
Current price unavailable — intrinsic value cannot be calculated. Financial fundamentals available below.
SAROJA Cash Flow Quality — Operating & Free Cash Flow
Saroja Pharma Industries operating cash flow, free cash flow, quality rating and sustainability score — key DCF inputs available despite missing price data.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹1 Cr | ₹-2 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹2 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
SAROJA Intrinsic Value — Price Data Required for DCF & Graham Number
Why is intrinsic value important?
Intrinsic value represents the true worth of a company based on its fundamentals, independent of market sentiment. It helps investors identify:
- Whether a stock is overvalued or undervalued
- Long-term investment opportunities
- Fair value ranges for entry and exit points
What happens when price data is unavailable?
While we cannot calculate intrinsic value without current market price, you can still assess the company's financial health using metrics like ROE, debt ratios, profitability margins, and cash flow quality shown above.
SAROJA Financial Health — Ratios, Margins & Debt Analysis
Saroja Pharma Industries profitability, liquidity and leverage ratios with ratings and interpretation — available without current price data.
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
Related Analysis
- For current market price and key ratios, visit Saroja Pharma Industries stock price NSE.
- Analyse Saroja Pharma Industries ownership pattern to track promoter, FII and institutional holdings.
- Read Saroja Pharma Industries dividend policy for the complete payout history and dividend yield track record.